Effect of fluoroquinolone treatment on the diagnosis of pulmonary tuberculosis:clinical analysis of 103 cases of tuberculosis misdiagnosed as community-acquired pneumonia

QIU Xian,LI Li,XU Hong,HUANG Wenjie

DOI: https://doi.org/10.3969/j.issn.1009-7708.2013.04.005

2013-01-01

Abstract:Objective To review and analyze the clinical characteristics of 103 cases of pulmonary tuberculosis which were misdiagnosed as community acquired pneumonia(CAP)to understand the effect of fluoroquinolone treatment on the diagnosis of pulmonary tuberculosis.Methods We conducted a hospital-based,retrospective case-control study of 103 pulmonary tuberculosis patients who initially were misdiagnosed as CAP and 103 true CAP patients.The patients with pulmonary tuberculosis were further classified as fluoroquinolone group and non-fluoroquinolone group based on whether they received fluoroquinolone therapy previously.Results Tuberculosis was more prevalent in rural residents.Tussiculation,hemoptysis,night sweating,marasmus,and rheumatoid signs were significantly more prevalent in the tuberculosis patients than in CAP patients(P<0.05),as well as the monocyte count,percentage of monocytes and platelet count(P<0.05).The imaging examinations showed exudation in the upper lung(49.5%).Pleural effusion was significantly more in the patients with pulmonary tuberculosis than in CAP patients(P<0.05).In the patients treated with fluoroquinolones,the diagnosis of tuberculosis and appropriate antimicrobial therapy was significantly delayed compared with the patients without prior fluoroquinolone therapy(P=0.000).Conclusions For patients with exudation in upper lobe of lung or pleural effusion revealed by X-Ray,pulmonary tuberculosis should be considered if the patient is refractory to CAP therapies.The first-line empirical treatment should exclude fluoroquinolones if possible.